To determine the functional capacity of PD-1 expression, we first selected PBMCs containing either viral epitope-specific PD-1+CD8+ T cells or apoptotic epitope-specific PD-1+CD8+ T cells from patients undergoing infection resolution or those experiencing chronic infection. Here, CD8A is linked to infection.